Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00276263
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine (N-methylglycine)

Indicates status has not been verified in more than two years